First thoughts should not be allowed to gloss over what is really a gut punch.
It’s unsurprising because the AI galaxy brains at DeepMind always looked like unlikely candidates for the quotidian, margins-focused business of selling and scaling software as a service. The app in question, a clinical task management and alerts app called Streams, does not involve any AI.
The algorithm it uses was developed by the UK’s own National Health Service, a branch of which DeepMind partnered with to co-develop Streams.
In a blog post announcing the hand-off yesterday, “scaling” was the precise word the DeepMind founders chose to explain passing their baby to Google . And if you want to scale apps Google does have the well oiled machinery to do it.
At the same time Google has just hired Dr. David Feinberg, from US health service organization Geisinger, to a new leadership role which CNBC reports as being intended to tie together multiple, fragmented health initiatives and coordinate its moves into the $3TR healthcare sector.
The company’s stated mission of ‘organizing the world’s information and making it universally accessible and useful’ is now seemingly being applied to its own rather messy corporate structure — to try to capitalize on growing opportunities for selling software to clinicians.
That health tech opportunities are growing is clear.
In the UK, where Streams and DeepMind Health operates, the minister for health, Matt Hancock, a recent transplant to the portfolio from the digital brief, brought his love of apps with him — and almost immediately made technology one of his stated priorities for the NHS.
Last month he fleshed his thinking out further, publishing a future of healthcare policy document containing a vision for transforming how the NHS operates — to plug in what he called “healthtech” apps and services, to support tech-enabled “preventative, predictive and personalised care”.
Which really is a clarion call to software makers to clap fresh eyes on the sector.
In the UK the legwork that DeepMind has done on the ‘apps for clinicians’ front — finding a willing NHS Trust to partner with; getting access to patient data, with the Royal Free passing over the medical records of some 1.6 million people as Streams was being developed in the autumn of 2015; inking a bunch more Streams deals with other NHS Trusts — is now being folded right back into Google.
And this is where things get shocking.
Shocking because DeepMind handing the app to Google — and therefore all the patient data that sits behind it — goes against explicit reassurances made by DeepMind’s founders that there was a firewall sitting between its health experiments and its ad tech parent, Google.
“In this work, we know that we’re held to the highest level of scrutiny,” wrote DeepMind co-founder Mustafa Suleyman in a blog post in July 2016 as controversy swirled over the scope and terms of the patient data-sharing arrangement it had inked with the Royal Free. “DeepMind operates autonomously from Google, and we’ve been clear from the outset that at no stage will patient data ever be linked or associated with Google accounts, products or services.”
As law and technology academic Julia Powles, who co-wrote a research paper on DeepMind’s health foray with the New Scientist journalist, Hal Hodson, who obtained and published the original (now defunct) patient data-sharing agreement, noted via Twitter: “This isn’t transparency, it’s trust demolition.”
If you enjoyed our content, we'd really appreciate some "love" with a share or two.
And ... Don't forget to have fun!